CPB
55
-2
BWA
56
3
BBY
60
2
CMG
50
-13
CVS
58
6
NEM
42
-6
PCAR
48
2
EQR
48
-2
PVH
58
4
IR
74
3
DRI
58
-2
MRO
42
-5
WHR
61
2
KSS
59
5
DE
56
3
IRM
71
-2
GM
55
3
PYPL
58
2
RCL
77
-4
FE
56
4
CPB
55
-2
BWA
56
3
BBY
60
2
CMG
50
-13
CVS
58
6
NEM
42
-6
PCAR
48
2
EQR
48
-2
PVH
58
4
IR
74
3
DRI
58
-2
MRO
42
-5
WHR
61
2
KSS
59
5
DE
56
3
IRM
71
-2
GM
55
3
PYPL
58
2
RCL
77
-4
FE
56
4
Financhill
Back

Hess Midstream LP Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
57

HESM
Hess Midstream LP

Last Price:
35.13
Seasonality Move:
5.45%
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
124.65
Seasonality Move:
-1.39%
Buy
57
Hess Midstream LP (HESM) is a Buy

Is Hess Midstream LP a Buy, Sell or Hold?

  • The current Hess Midstream LP [HESM] share price is $35.19. The Score for HESM is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • HESM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HESM Stock Price Chart

What is Hess Midstream LP's stock price today?

  • The Hess Midstream LP share price today is $35.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HESM is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $124.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

HESM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.29 Sell
Relative Strength Index (14 RSI): 41.29 Sell
Chaikin Money Flow: 499015 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.55 - 36.93) Sell
Bollinger Bands (100): (35.12 - 37.3) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.18 Sell
Relative Strength Index (14 RSI): 35.54 Sell
Chaikin Money Flow: -49995 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.27 - 135.95) Sell
Bollinger Bands (100): (123.89 - 147.49) Sell

HESM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.69 Sell
20-day SMA: 36.09 Sell
50-day SMA: 36.45 Sell
200-day SMA: 35.02 Buy
8-day EMA: 35.62 Sell
20-day EMA: 35.98 Sell
50-day EMA: 36.23 Sell
200-day EMA: 34.93 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.45 Sell
20-day SMA: 127.75 Sell
50-day SMA: 135.2 Sell
200-day SMA: 127.53 Sell
8-day EMA: 125.39 Sell
20-day EMA: 128.04 Sell
50-day EMA: 132.59 Sell
200-day EMA: 128.64 Sell

Hess Midstream LP Earnings Growth & HESM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.10 per share, an increase this year of $0.43 per share, and an increase next year of $0.58 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Hess Midstream LP Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):